8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed May 5, 2026 · 2mo ago · Accession 0001193125-26-206395
Plain English
Standard BioTools Inc. reported its financial results for the three months ended March 31, 2026, including revenue of "$21.1 million" and an adjusted EBITDA loss of "$3.1 million". The company also provided its full year 2026 revenue outlook.
Filing details
- Company
- STANDARD BIOTOOLS INC.
- Ticker
- LAB
- CIK
- 1162194
- Form type
- 8-K
- Filing date
- May 5, 2026
- Report date
- May 5, 2026
- Document
- lab-20260505.htm
- Size
- 845 KB